| Cash flow (USD) | FY 2026 ended Jun 30, 2026 | FY 2025 ended Jun 30, 2025 | FY 2024 ended Jun 30, 2024 | FY 2024 ended Jun 30, 2023 |
|---|---|---|---|---|
| Net income | -19.30M | -46.88M | -18.46M | -48.81M |
| Depreciation and amortization | 240.0K | 246.0K | 103.0K | 88.0K |
| Stock-based compensation | 7.56M | 2.61M | 8.93M | 2.15M |
| Cash from operations | -12.87M | -12.51M | -15.85M | -10.75M |
| Capital expenditure | -10.0K | -8.0K | -277.0K | -316.0K |
| Free cash flow | -12.88M | -12.52M | -16.12M | -11.06M |
| Cash from investing | -94.0K | -8.0K | -277.0K | -316.0K |
| Share buybacks | -9.40M | 0 | ||
| Cash from financing | 65.90M | 21.40M | 8.18M | |
| Net change in cash | 52.94M | 8.88M | -16.12M | -2.89M |
From Incannex Healthcare Inc.'s 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.